摘要
目的:探讨IL-4、IL-15、IL-18在重症肌无力(MG)中的表达及其与CD4+T淋巴细胞端粒酶活性的相关关系。方法:应用ELISA及重复扩增-酶联免疫吸附实验(PCR-ELISA)检测30例MG患者(MG组)和30例健康对照者(NC组)血清中的IL-4、IL-15、IL-18水平和CD4+T淋巴细胞端粒酶活性。结果:MG组血清IL-4、IL-15、IL-18水平及CD4+T淋巴细胞端粒酶活性显著高于NC组,差异具有统计学意义(P<0.01);MG组CD4+T淋巴细胞端粒酶活性与血清IL-4、IL-15、IL-18水平均存在正相关关系(P<0.01)。结论:IL-4、IL-15、IL-18及CD4+T淋巴细胞端粒酶均参与了MG的发病过程;MG中IL-4、IL-15及IL-18有可能通过各种途径直接或间接的上调CD4+T淋巴细胞的端粒酶的活性。
Objective: To detect the serum levels of IL-4, IL-15 and IL-18 in myasthenia gravis(MG) and investigate the correlations between telomerase activity of CD4+ T lymphocytes and these interleukins. Methods: The serum levels of IL-4, IL-15 and IL-18 were detected with ELISA and telomerase activity was detected by polymerase chain reaction enzyme-linked immonosorbent assay(PCR-ELISA) in 30 MG pa- tients and 30 negative controls. Results: The levels of IL-4, IL-15, IL- 18 and telomerase of CD4+ T lymphocytes in MG were significantly higher than those in negative controls (P 〈 0.01 ). There were positive correlations between the serum levels of IL-4, IL-15, IL-18 and telomerase activity of CD4+ + T cell in MG patients (P 〈 0.01 ). Conclusion: IL-4, IL-15, IL-18 and telomerase activity of CD4 + T lymphocytes are involved in the pathogenesis of MG; IL-4, IL-15 and IL-18 may upregulate the telomerase activity of CD4+ T cells.
出处
《中国免疫学杂志》
CAS
CSCD
北大核心
2009年第11期1006-1008,共3页
Chinese Journal of Immunology